eosin h e staining kit (Beyotime)
Structured Review
Eosin H E Staining Kit, supplied by Beyotime, used in various techniques. Bioz Stars score: 99/100, based on 1946 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/eosin+staining+kit/Hematoxylin+and+Eosin+Staining+Kit/pmc13097096-64-7-21
Average 99 stars, based on 1946 article reviews
Images
Related Articles
Lysis:Article Title: Skin bacteriota ameliorates androgenetic alopecia via harmonizing skin immuno inflammatory balance Article Snippet: The mixed antibiotics consisted of polymyxin B sulfate (Meilunbio, 1405-20−5) 200 μg/mL, glycopeptide (Solarbio, B8181) 200 μg/mL, streptomycin sulfate (Solarbio, S8290) 100 μg/mL and ciprofloxacin (Solarbio, C9710) 250 μg/mL, ceftazidime (Solarbio, C9730) 200 μg/mL were configured. .. Anti-Wnt5a (BOSTER, BA2839), anti-β-catenin (BOSTER, BA0426), anti-GAPDH (BOSTER, A00227-1), Anti-TLR4 (BOSTER, A00017-3), and anti-NF-κB (BOSTER, BA0610), RIPA Lysis Buffer (Beyotime, P0013K), BeyoBCA Rapid Protein Assay Kit (Beyotime, P0398L), BeyoECL Plus (Beyotime, P0018M), RNase H- kit (Beyotime, D7168M), Hematoxylin and Article Title: Design and synthesis of novel ATP-citrate lyase inhibitors and their effects on MAFLD/MASH. Article Snippet: ATP-citrate lyase (ACLY) has emerged as a promising therapeutic target for metabolic dysfunction-associated fatty liver disease (MAFLD) and metabolic dysfunction-associated steatohepatitis (MASH).. Inspired by the common pharmacophore of natural ACLY inhibitors, we designed and synthesized a novel series of chalconeskeleton derivatives.. Extensive structure-activity relationship (SAR) studies revealed that introducing conformational constraint, particularly through five-membered ring formation (e.g., compound B1) or a rigid benzofuran scaffold (e.g., compound C1), remarkably enhanced ACLY inhibition. Staining:Article Title: Skin bacteriota ameliorates androgenetic alopecia via harmonizing skin immuno inflammatory balance Article Snippet: The mixed antibiotics consisted of polymyxin B sulfate (Meilunbio, 1405-20−5) 200 μg/mL, glycopeptide (Solarbio, B8181) 200 μg/mL, streptomycin sulfate (Solarbio, S8290) 100 μg/mL and ciprofloxacin (Solarbio, C9710) 250 μg/mL, ceftazidime (Solarbio, C9730) 200 μg/mL were configured. .. Anti-Wnt5a (BOSTER, BA2839), anti-β-catenin (BOSTER, BA0426), anti-GAPDH (BOSTER, A00227-1), Anti-TLR4 (BOSTER, A00017-3), and anti-NF-κB (BOSTER, BA0610), RIPA Lysis Buffer (Beyotime, P0013K), BeyoBCA Rapid Protein Assay Kit (Beyotime, P0398L), BeyoECL Plus (Beyotime, P0018M), RNase H- kit (Beyotime, D7168M), Hematoxylin and Article Title: UFMylation deficiency in hepatocytes activates the KEAP1-NRF2 pathway and contributes to hepatocarcinogenesis Article Snippet: The slides were subsequently counterstained with hematoxylin (C0107, Beyotime Biotechnology) for 1 min and mounted in Neutral Balsam Mounting Medium (E675007, Sangon Biotech, Shanghai, China). .. H&E staining was performed with a Hematoxylin and Article Title: Hyaluronic acid-mediated artemisinin/ferrocene co-delivery Nanoplatform enhances immune checkpoint blockade response by triggering tumor cell immunogenic cell death via H₂O₂-independent Chemodynamic therapy. Article Snippet: A R T I C L E I N F O Article Title: Initiating Events of Retinopathy in Spontaneously Hypertensive Rats: Microvascular Rarefaction and Functional Deficits Article Snippet: Hypertension.. 2026;83:e26116.. DOI: 10.1161/HYPERTENSIONAHA.125.26116 June 2026 1 Correspondence to: Xiaohong Yang, School of Medicine, South China University of Technology, Guangzhou, People’s Republic of China, Email syyangxh@scut.edu.cn; or Lei Liu, Guangdong Eye Institute, Department of Ophthalmology, Guangdong Provincial People’s Hospital (Guangdong Academy of Medical Sciences), Guangzhou, People’s Republic of China, Email liulei@gdph.org.cn; or Honghua Yu, Guangdong Eye Institute, Department of Ophthalmology, Guangdong Provincial People’s Hospital (Guangdong Academy of Medical Sciences), Guangzhou, People’s Republic of China, Email yuhonghua@gdph.org.cn Supplemental Material is available at https://www.ahajournals.org/doi/suppl/10.1161/HYPERTENSIONAHA.125.26116. Article Title: Efficacy and safety of topical human keratinocyte growth factor-2 for dry eye disease: evidence from in vivo studies Article Snippet: Scopolamine hydrobromide (SCOP, Cat# S817762) was purchased from Macklin (Shanghai, China). .. Hematoxylin and Article Title: Design and synthesis of novel ATP-citrate lyase inhibitors and their effects on MAFLD/MASH. Article Snippet: ATP-citrate lyase (ACLY) has emerged as a promising therapeutic target for metabolic dysfunction-associated fatty liver disease (MAFLD) and metabolic dysfunction-associated steatohepatitis (MASH).. Inspired by the common pharmacophore of natural ACLY inhibitors, we designed and synthesized a novel series of chalconeskeleton derivatives.. Extensive structure-activity relationship (SAR) studies revealed that introducing conformational constraint, particularly through five-membered ring formation (e.g., compound B1) or a rigid benzofuran scaffold (e.g., compound C1), remarkably enhanced ACLY inhibition. Article Title: Mini‐Catalytically Inactive Cas13X‐Derived RNA Base Editing of β‐Catenin Attenuates Pulmonary Damage in a Murine Acute Lung Injury Model Article Snippet: .. For histology analysis, the lung tissues were cut coronally to obtain 5 μm and were stained with Hematoxylin and Article Title: Perfluorooctane sulfonic acid impairs spermatogenesis via the liver-gut microbiota-testis axis: a central role of chenodeoxycholic acid metabolism Article Snippet: .. Histopathological evaluation was performed using a Hematoxylin and MTT Assay:Article Title: Hyaluronic acid-mediated artemisinin/ferrocene co-delivery Nanoplatform enhances immune checkpoint blockade response by triggering tumor cell immunogenic cell death via H₂O₂-independent Chemodynamic therapy. Article Snippet: A R T I C L E I N F O Reductase Assay:Article Title: Hyaluronic acid-mediated artemisinin/ferrocene co-delivery Nanoplatform enhances immune checkpoint blockade response by triggering tumor cell immunogenic cell death via H₂O₂-independent Chemodynamic therapy. Article Snippet: A R T I C L E I N F O ATP Assay:Article Title: Hyaluronic acid-mediated artemisinin/ferrocene co-delivery Nanoplatform enhances immune checkpoint blockade response by triggering tumor cell immunogenic cell death via H₂O₂-independent Chemodynamic therapy. Article Snippet: A R T I C L E I N F O Enzyme-linked Immunosorbent Assay:Article Title: Hyaluronic acid-mediated artemisinin/ferrocene co-delivery Nanoplatform enhances immune checkpoint blockade response by triggering tumor cell immunogenic cell death via H₂O₂-independent Chemodynamic therapy. Article Snippet: A R T I C L E I N F O Recombinant:Article Title: Hyaluronic acid-mediated artemisinin/ferrocene co-delivery Nanoplatform enhances immune checkpoint blockade response by triggering tumor cell immunogenic cell death via H₂O₂-independent Chemodynamic therapy. Article Snippet: A R T I C L E I N F O Western Blot:Article Title: Design and synthesis of novel ATP-citrate lyase inhibitors and their effects on MAFLD/MASH. Article Snippet: ATP-citrate lyase (ACLY) has emerged as a promising therapeutic target for metabolic dysfunction-associated fatty liver disease (MAFLD) and metabolic dysfunction-associated steatohepatitis (MASH).. Inspired by the common pharmacophore of natural ACLY inhibitors, we designed and synthesized a novel series of chalconeskeleton derivatives.. Extensive structure-activity relationship (SAR) studies revealed that introducing conformational constraint, particularly through five-membered ring formation (e.g., compound B1) or a rigid benzofuran scaffold (e.g., compound C1), remarkably enhanced ACLY inhibition. Blocking Assay:Article Title: Design and synthesis of novel ATP-citrate lyase inhibitors and their effects on MAFLD/MASH. Article Snippet: ATP-citrate lyase (ACLY) has emerged as a promising therapeutic target for metabolic dysfunction-associated fatty liver disease (MAFLD) and metabolic dysfunction-associated steatohepatitis (MASH).. Inspired by the common pharmacophore of natural ACLY inhibitors, we designed and synthesized a novel series of chalconeskeleton derivatives.. Extensive structure-activity relationship (SAR) studies revealed that introducing conformational constraint, particularly through five-membered ring formation (e.g., compound B1) or a rigid benzofuran scaffold (e.g., compound C1), remarkably enhanced ACLY inhibition. |
